1. de Wit, MA, et al. Gastroenteritis in sentinel general practices, The Netherlands. Emerging Infectious Diseases 2001; 7: 82–91.
2. de Wit, MA, et al. Etiology of gastroenteritis in sentinel general practices in The Netherlands. Clinical Infectious Diseases 2001; 33: 280–288.
3. Amar, CF, Dear, PH, McLauchlin, J. Detection and identification by real time PCR/RFLP analyses of Cryptosporidium species from human faeces. Letters in Applied Microbiology 2004; 38: 217–222.
4. Amar, CF, et al. Detection of viral, bacterial, and parasitological RNA or DNA of nine intestinal pathogens in fecal samples archived as part of the english infectious intestinal disease study: assessment of the stability of target nucleic acid. Diagnostic Molecular Pathology 2005; 14: 90–96.
5. Amar, CF, et al. Detection by PCR of eight groups of enteric pathogens in 4627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993–1996). European Journal of Clinical Microbiology & Infectious Diseases 2007; 26: 311–323.
6. Simpson, R, et al. Infantile viral gastroenteritis: on the way to closing the diagnostic gap. Journal of Medical Virology 2003; 70: 258–262.
7. Iturriza, Gomara M, et al. Structured surveillance of infantile gastroenteritis in East Anglia, UK: incidence of infection with common viral gastroenteric pathogens. Epidemiology and Infection 2008; 136: 23–33.
8. Djuretic, T, et al. An estimate of the proportion of diarrhoeal disease episodes seen by general practitioners attributable to rotavirus in children under 5 y of age in England and Wales. Acta Paediatrica (Suppl.) 1999; 88: 38–41.
9. Birmingham Research Unit of the Royal College of General Practitioners. Weekly Returns Service Annual Report, 2006.
10. Boom, R, et al. Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 1990; 28: 495–503.
11. Iturriza-Gómara, M, et al. Comparison of specific and random priming in the reverse transcriptase polymerase chain reaction for genotyping group A rotaviruses. Journal of Virological Methods 1999; 78: 93–103.
12. Iturriza-Gomara, M, Kang, G, Gray, J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. Journal of Clinical Microbiology 2004; 31: 259–265.
13. Kageyama, T, et al. Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription–PCR. Journal of Clinical Microbiology 2003; 41: 1548–1557.
14. Gallimore, CI, et al. Inter-seasonal diversity of norovirus genotypes: emergence and selection of virus variants. Archives of Virology 2007; 152: 1295–1303.
15. Svraka, S, et al. Etiological role of viruses in outbreaks of acute gastroenteritis in The Netherlands from 1994 through 2005. Journal of Clinical Microbiology 2007; 45: 1389–1394.
16. Gallimore, CI, Richards, AF, Gray, JJ. Molecular diversity of noroviruses associated with outbreaks on cruise ships: comparison with strains circulating within the UK. Communicable Disease and Public Health 2003; 6: 285–293.
17. Gallimore, CI, et al. Diversity of Noroviruses cocirculating in the North of England from 1998 to 2001. Journal of Clinical Microbiology 2004; 42: 1396–1401.
18. Lopman, B, et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 2004; 363: 682–688.
19. Allen, DJ, et al. Analysis of amino acid variation in the P2 domain of the GII-4 Norovirus VP1 protein reveals putative variant-specific epitopes. PLoS ONE 2008; 3: e1485.
20. de Wit, MA, et al. A comparison of gastroenteritis in a general practice-based study and a community-based study. Epidemiology and Infection 2001; 127: 389–397.
21. Soriano-Gabarro, M, et al. Burden of rotavirus disease in European Union countries. Pediatric Infectious Disease Journal 2006; 25 (1 Suppl.): S7–S11.
22. Harris, JP, et al. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Vaccine 2007; 25: 3962–3970.
23. Jit, M, et al. Estimating the number of deaths with rotavirus as a cause in England and Wales. Human Vaccines 2007; 3: 23–26.
24. Lorgelly, PK, et al. Infantile gastroenteritis in the community: a cost-of-illness study. Epidemiology and Infection 2008; 136: 34–43.
25. Vesikari, T, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370: 1757–1763.
26. Vesikari, T, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New England Journal of Medicine 2006; 354: 23–33.